192 related articles for article (PubMed ID: 15973459)
41. Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects.
Karpuj MV; Steinman L; Oksenberg JR
Neurogenetics; 1997 May; 1(1):21-8. PubMed ID: 10735270
[TBL] [Abstract][Full Text] [Related]
42. Autoimmunity in systemic lupus erythematosus: integrating genes and biology.
Krishnan S; Chowdhury B; Tsokos GC
Semin Immunol; 2006 Aug; 18(4):230-43. PubMed ID: 16713714
[TBL] [Abstract][Full Text] [Related]
43. EVI5 is a risk gene for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of disease: the genetic epidemiology of gallbladder stones.
Lammert F; Sauerbruch T
Nat Clin Pract Gastroenterol Hepatol; 2005 Sep; 2(9):423-33. PubMed ID: 16265433
[TBL] [Abstract][Full Text] [Related]
45. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.
Galimberti D; Scalabrini D; Fenoglio C; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Leone M; Dianzani U; D'Alfonso S; Monaco F; Bresolin N; Scarpini E
J Neurol Sci; 2008 Apr; 267(1-2):86-90. PubMed ID: 17967467
[TBL] [Abstract][Full Text] [Related]
46. The sex-specific genetic architecture of quantitative traits in humans.
Weiss LA; Pan L; Abney M; Ober C
Nat Genet; 2006 Feb; 38(2):218-22. PubMed ID: 16429159
[TBL] [Abstract][Full Text] [Related]
47. Perils in the use of linkage disequilibrium for fine gene mapping: simple insights from population genetics.
Gorroochurn P
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3292-7. PubMed ID: 19064541
[TBL] [Abstract][Full Text] [Related]
48. Current status of genome-wide scanning for hypertension.
Hamet P; Seda O
Curr Opin Cardiol; 2007 Jul; 22(4):292-7. PubMed ID: 17556880
[TBL] [Abstract][Full Text] [Related]
49. Genomewide study of multiple sclerosis.
Chaudhuri A; Behan PO
N Engl J Med; 2007 Nov; 357(21):2200; author reply 2200-1. PubMed ID: 18038461
[No Abstract] [Full Text] [Related]
50. Complex approaches to study complex trait genetics in multiple sclerosis.
Kálmán B
Ideggyogy Sz; 2014 Sep; 67(9-10):309-21. PubMed ID: 25518259
[TBL] [Abstract][Full Text] [Related]
51. Multiple sclerosis: postlinkage genetics.
Hillert J
Clin Neurol Neurosurg; 2006 Mar; 108(3):220-2. PubMed ID: 16413964
[TBL] [Abstract][Full Text] [Related]
52. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
[TBL] [Abstract][Full Text] [Related]
53. Association of multiple sclerosis with ILT6 deficiency.
Koch S; Goedde R; Nigmatova V; Epplen JT; Müller N; de Seze J; Vermersch P; Momot T; Schmidt RE; Witte T
Genes Immun; 2005 Aug; 6(5):445-7. PubMed ID: 15815690
[TBL] [Abstract][Full Text] [Related]
54. [The rational basis of the newer treatments used in multiple sclerosis].
Fernández O
Rev Neurol; 2000 Jun 16-30; 30(12):1257-64. PubMed ID: 10935261
[TBL] [Abstract][Full Text] [Related]
55. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms.
Greer JM; McCombe PA
J Neuroimmunol; 2011 May; 234(1-2):7-18. PubMed ID: 21474189
[TBL] [Abstract][Full Text] [Related]
56. The immunological basis of current and novel therapies of multiple sclerosis.
Dubois B; Opdenakker G
Arch Immunol Ther Exp (Warsz); 1999; 47(1):7-16. PubMed ID: 11729832
[TBL] [Abstract][Full Text] [Related]
57. Genetics of multiple sclerosis.
Oksenberg JR; Hauser SL
Neurol Clin; 2005 Feb; 23(1):61-75, vi. PubMed ID: 15661088
[No Abstract] [Full Text] [Related]
58. Immunotherapy of multiple sclerosis: where are we? Where should we go?
Martin R; Stürzebecher CS; McFarland HF
Nat Immunol; 2001 Sep; 2(9):785-8. PubMed ID: 11526386
[No Abstract] [Full Text] [Related]
59. Multiple sclerosis and gender.
Darlington C
Curr Opin Investig Drugs; 2002 Jun; 3(6):911-4. PubMed ID: 12137412
[No Abstract] [Full Text] [Related]
60. An array of possibilities for the study of autoimmunity.
Fathman CG; Soares L; Chan SM; Utz PJ
Nature; 2005 Jun; 435(7042):605-11. PubMed ID: 15931213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
